Skip to search formSkip to main contentSkip to account menu

BMS-790052

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Imidazoles

Narrower (1)

daclatasvir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
HCV NS5A Inhibitors in Development
  • A. Lok
  • 2013
  • Corpus ID: 196384714
Review
2013
Review
2013
HCV NS5A inhibitors in development.
2013
2013
Low rates of naturally occurring resistant variants to the NS5A inhibitor daclatasvir in HCV‐1 null responders
We read with interest the article by Sun et al. evaluating the influence of naturally occurring polymorphisms on the potency of… 
2012
2012
HCV NS5A replication complex inhibitors. Part 2: investigation of stilbene prolinamides.
Highly Cited
2012
Highly Cited
2012
Lucidone Suppresses Hepatitis C Virus Replication by Nrf2-Mediated Heme Oxygenase-1 Induction
ABSTRACT Upon screening of plant-derived natural products against hepatitis C virus (HCV) in the replicon system, we demonstrate… 
2012
2012
Calamitous HCV trial casts shadow over nucleoside drugs
1015 The BMS-986094 molecule, an inhibitor of the HCV RNA polymerase nonstructural protein 5B (NS5B), is an aryl-phosphoramidate… 
2012
2012
1193 A DESCRIPTION OF VIROLOGIC ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH DACLATASVIR (BMS-790052) IN COMBINATION WITH RIBAVIRIN AND PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B
Review
2011
Review
2011
The era of direct-acting antivirals has begun: the beginning of the end for HCV?
The year 2011 marks the dawn of the new era of direct-acting antivirals for hepatitis C. For the first time since 1998, the U.S… 
2011
2011
63 CHARACTERIZATION OF VIROLOGIC ESCAPE IN HCV GENOTYPE 1 NULL RESPONDERS RECEIVING A COMBINATION OF THE NS3 PROTEASE INHIBITOR BMS-650032 AND NS5A INHIBITOR BMS-790052
2011
2011
A rugged and accurate liquid chromatography-tandem mass spectrometry method for quantitative determination of BMS-790052 in plasma.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)